Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04852406

Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy: a Pragmatic Interventional Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
526 (estimated)
Sponsor
Peking University First Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this pragmatic interventional study is to evaluate whether a protocol-based management of antithrombotic drugs can reduce a composite of perioperative outcomes in patients with chronic antithrombotic therapy before surgery.

Detailed description

Aging population and chronic medical disease make the management of surgical patients more complex. About one tenth of patients scheduled for surgery are taking antithrombotic medications. Coagulation disturbance induced by these medications may increase the risk of bleeding, whereas withholding these medications may increase the risk of thrombotic events. It is a dilemma when managing these patients. The guidelines and expert consensus published by multiple disciplinary teams constitute the perioperative antithrombotic management protocols. However, the effects of perioperative antithrombotic management guided by these guidelines or expert consensus are seldom reported. The investigators hypothesize that a protocol-based perioperative antithrombotic management can benefit patients with chronic antithrombotic therapy before surgery.

Conditions

Interventions

TypeNameDescription
DRUGProtocol-based management of perioperative antithrombotic therapyPerioperative antithrombotic therapy is managed according to the latest expert consensus published in the Chinese Medical Journal, 2020.
DRUGRoutine management of perioperative antithrombotic therapyPerioperative antithrombotic therapy is managed according to current routine practice.

Timeline

Start date
2021-04-21
Primary completion
2025-12-01
Completion
2026-01-01
First posted
2021-04-21
Last updated
2025-07-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04852406. Inclusion in this directory is not an endorsement.